Bigfoot Biomedical Stock
Medical Device Company
Sign up today and learn more about Bigfoot Biomedical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Bigfoot Biomedical Stock
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
Investors
Abbott Biotech Ventures
Cormorant Asset Management
Janus Capital Group
JDRF T1D Fund
Quadrant Capital Advisors
Senvest Capital
Visionnaire Ventures
Funding History
| November 2014 | $2.0M |
|---|---|
| October 2016 | $35.5M |
| December 2017 | $37.0M |
| March 2018 | $18.0M |
| January 2020 | $45.0M |
Management
Chief Executive Officer
Brewer Jeffrey
Chief Financial Officer
Brett Hale
Chief Operating Officer
Ian Hanson
Press
thefly - Sep, 22 2023
Abbott completes acquisition of Bigfoot Biomedicalmpo-mag - Sep, 7 2023
Abbott and Bigfoot Biomedical Finally Get Hitchedfiercebiotech - Sep, 7 2023
Abbott tracks down Bigfoot Biomedical in deal to combine diabetes techseekingalpha - Sep, 6 2023
Abbott acquires Bigfoot Biomedical, furthers growth of personalized solutions for diabeticsfiercebiotech - Mar, 31 2023
Bigfoot Biomedical steps up diabetes tech with acquisition of auto-adjusting insulin dosing algorithmfiercebiotech - Mar, 5 2023
Bigfoot Biomedical expands footprint of connected diabetes system with FDA nod for Android appbusinesswire - Feb, 13 2023
Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologiesdrugdeliverybusiness - Jan, 29 2022
How Bigfoot Biomedical plans to take diabetes management forwardca - Dec, 23 2021
Bigfoot Biomedical® Adds Depth With Experienced, Senior New Hiresdrugdeliverybusiness - Dec, 18 2021
Bigfoot Biomedical announces trio of new senior hiresdrugdeliverybusiness - Dec, 3 2021
Bigfoot Biomedical touts cloud-based program for managing diabetesdrugdeliverybusiness - Jun, 25 2021
Bigfoot Biomedical diabetes management program rolls out in some U.S. statesmobihealthnews - May, 10 2021
FDA greenlights Bigfoot Biomedical's insulin recommending diabetes management systemmassdevice - Dec, 10 2020
Bigfoot Biomedical appoints commercial teammobihealthnews - Jun, 4 2020
Bigfoot Biomedical caps off its Series C funding at $55M, including a new $10M additionmassdevice - Jun, 3 2020
Bigfoot Biomedical raises $55m in Series Czpr - Jun, 3 2020
Bigfoot Biomedical® Closes Series C Financing with $55 Million as Company Readies for FDA Submission of Bigfoot Unityvcaonline - Jun, 3 2020
Venture Capital Database 2020 Now Available!Business Wire - Jun, 2 2020
Bigfoot Biomedical® Closes Series C Financing with $55 Million as Company Readies for FDA Submission of Bigfoot Unitymassdevice - Feb, 19 2020
Insulet partners with Abbott and Dexcom on automated insulin deliverypulse2 - Jan, 30 2020
Bigfoot Biomedical: How This Company Is Focused On Optimizing Insulin Deliverymobihealthnews - Jan, 16 2020
Bigfoot Biomedical announces $45M Series C tranche, expands partnership with Abbottmedcitynews - Jan, 16 2020
Bigfoot Biomedical lands $45M as it readies first diabetes productmassdevice - Aug, 1 2019
Bigfoot Biomedical inks deal with Pittsburgh health systemmedtechdive - Jan, 22 2019
Bigfoot could shake up insulin delivery market, analyst saysdrugdeliverybusiness - Jan, 7 2019
Bigfoot Biomedical inks insulin deal with Eli Lillypehub - Mar, 30 2018
Diabetes startup Bigfoot Biomedical hauls in $55 mln Series Bmobihealthnews - Mar, 29 2018
Bigfoot Biomedical closes Series B financing round with $55Mdrugdeliverybusiness - Mar, 28 2018
Bigfoot brings Series B total to $55m with new investment from Abbottcnbc - Mar, 28 2018
Abbott invests in diabetes care start-upmedicaldesignandoutsourcing - Dec, 22 2017
7 top stories that mattered for medtech in 2017medcitynews - Dec, 21 2017
Bigfoot Biomedical closes $37M Series B as it prepares for clinical trials of insulin delivery techmddionline - Dec, 20 2017
10 Medtech Startups that Turned Heads in 2017biospace - Dec, 20 2017
Bay Area Bigfoot Biomedical Bags $37M Series B Financingfiercebiotech - Dec, 20 2017
Bigfoot raises $37M to trial AI-enabled insulin delivery devicesmobihealthnews - Dec, 20 2017
Bigfoot Biomedical's automated insulin delivery systems attract $37M in Series B fundingcontinuuminnovation - Dec, 20 2017
Mission Controlpehub - Dec, 19 2017
Bigfoot Biomedical rakes in $37 mlnbusinesswire - Dec, 18 2017
Bigfoot Biomedical Announces Initial $37 Million of awsj - Dec, 18 2017
Bigfoot Biomedical Raises $37 Million for Diabetes Deviceasweetlife - Dec, 8 2017
7 Diabetes Technology Updates for 2018mddionline - Dec, 8 2017
Medtech Company of the Year 2017 Finalistsmassdevice - Nov, 16 2017
Bigfoot Biomedical CEO hits back against CMS over data-sharing decisiondigitalhealthtoday - Nov, 16 2017
#047: Jeffrey Brewer on Simplifying Diabetes Management Systemsbloombergquint - Nov, 4 2017
Diabetes Devices Move From Painful Fingerpricks to Slick Technytimes - Nov, 4 2017
A Diabetes Monitor That Spares the Fingersmassdevice - Oct, 12 2017
Here’s how the diabetes industry’s leaders think about patient-centered R&Dmddionline - Sep, 29 2017
How Abbott's Big Win Crushed DexCom Sharesdrugdeliverybusiness - Sep, 29 2017
Why Bigfoot Biomedical’s CEO thinks the diabetes industry has a data problemasweetlife - Aug, 2 2017
Bigfoot Biomedical Chooses Abbott’s Libre Over Dexcom’s CGMmedicaldesignandoutsourcing - Jul, 23 2017
Why Abbott’s CEO is excited about Bigfoot Biomedical and diabetes treatmentqmed - Jul, 18 2017
BigFoot Taps Abbott to Close Diabetes Treatment Loopmedtech - Jul, 18 2017
Bigfoot and Abbott Join Forces to Develop and Commercialize Diabetes Management Systemsreuters - Jul, 18 2017
BRIEF-Abbott, Bigfoot Biomedical enter deal to develop diabetes management systemsdrugdeliverybusiness - Jul, 18 2017
Bigfoot Biomedical’s CEO talks disruption in diabetes management techmobihealthnews - Jul, 18 2017
Abbott, Bigfoot Biomedical collaborate on diabetes technologieshealthline - Jul, 18 2017
NEWS: Bigfoot Closed Loop to Use Next-Gen Abbott FreeStyle Librefiercebiotech - Jul, 18 2017
Bigfoot picks Abbott glucose sensor for insulin delivery techdiatribe - Jul, 18 2017
Bigfoot & Abbott to Automate Insulin Delivery Without Fingersticksmedcitynews - Jul, 18 2017
New Abbott diabetes deal is a “missed opportunity” for DexComdrugdeliverybusiness - Jul, 18 2017
Bigfoot Biomedical taps Abbott to collaborate on automated insulin delivery techvator - Apr, 28 2017
Video: Jeffrey Brewer at Vator Splash Health 2017youtube - Mar, 30 2017
Vator Splash Health 2017 - Building artificial pancreas to treat diabetes (Jeffrey Brewer, Bigfoot)vator - Mar, 14 2017
Most Well-funded Healthtech Startups and Blue-chip VCsvator - Feb, 21 2017
Most well-funded healthtech startups and top VCs gathermassdevice - Feb, 9 2017
JDRF backs Bigfoot Biomedical with equity investmentmobihealthnews - Jan, 30 2017
Bigfoot Biomedical gets investment from JDRF's new venture fund for smart automated insulin delivery systemstatnews - Jan, 27 2017
New philanthropic venture fund launches to invest in companies tackling type 1 diabetesprnewswire - Dec, 4 2016
Global biopharma investment kicks off at Biotech Showcase™ 2017 in Januaryinsulinnation - Oct, 7 2016
I Was Hooked Up to Bigfoot’s Artificial Pancreashealthline - Jul, 26 2016
NEWSFLASH: Bigfoot to Kick Off Closed Loop Clinical Trial!diatribe - Jul, 26 2016
The Biggest Opportunities and Challenges in Digital Health - Hear from Global Leaders!medicaldesignandoutsourcing - Jul, 26 2016
Ones to Watch, ten companies we’re keeping an eye onqmed - Jul, 26 2016
Artificial Pancreas Race Includes a Motivated Underdogfiercebiotech - Jul, 26 2016
Bigfoot Biomedical starts clinical trial for artificial pancreasdiscovermagazine - Apr, 24 2016
Artificial Pancreas Makers Race to Marketmyglu - Apr, 24 2016
Closing the Loop, One Bigfoot Step at a Timeinsulinnation - Apr, 24 2016
Bigfoot’s Artificial Pancreas Could Hit the Market by 2018asweetlife - Apr, 24 2016
Making It Simple: Bigfoot’s Approach to the Artificial Pancreasdiatribe - Jan, 27 2016
Bigfoot Biomedical Reveals Its Automated Insulin Delivery System!hbr - Oct, 13 2015
The Innovative Mindset Your Company Can’t Afford to Losewsj - Jun, 14 2015
Computer Experts Deliver Insulin to Diabetic Kidsdiatribe - Jun, 4 2015
Bigfoot Biomedical Acquires Asante’s Snap Pump Technologymedcitynews - May, 14 2015
Bigfoot Biomedical raising a $15M Series A for its artificial pancreasdiatribe - Mar, 12 2015
Bigfoot Biomedical Sets its Sights on Simplifying Type 1 Diabetes Managementhealthline - Mar, 12 2015
The Bigfoot Family: Their Diabetes and Homemade Closed Loop SystemEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
